个人信息Personal Information
研究员
博士生导师
硕士生导师
性别:男
毕业院校:德国马普高分子所
学位:博士
所在单位:化工学院
办公地点:大连理工大学西部校区E-226
联系方式:sunwen@dlut.edu.cn
电子邮箱:sunwen@dlut.edu.cn
Superoxide Radical Photogenerator with Amplification Effect: Surmounting the Achilles' Heels of Photodynamic Oncotherapy
点击次数:
论文类型:期刊论文
发表时间:2019-02-13
发表刊物:Journal of the American Chemical Society
收录刊物:PubMed
卷号:141
期号:6
页面范围:2695-2702
ISSN号:1520-5126
关键字:Energy transfer; Photons; Tumors, Amplification effects; Dose irradiation; Intravenous injections; Photodynamic therapy (PDT); Resonance energy transfer; Signal-to-background ratio; Superoxide radical; Tumor proliferation, Photodynamic therapy
摘要:Strong oxygen dependence, poor tumor targeting, and limited treatment depth have been considered as the "Achilles' heels" facing the clinical usage of photodynamic therapy (PDT). Different from common approaches, here, we propose an innovative tactic by using photon-initiated dyad cationic superoxide radical (O2-•) generator (ENBOS) featuring "0 + 1 > 1" amplification effect to simultaneously overcome these drawbacks. In particular, by taking advantage of the Förster resonance energy transfer theory, the energy donor successfully endows ENBOS with significantly enhanced NIR absorbance and photon utility, which in turn lead to ENBOS more easily activated and generating more O2-• in deep tissues, that thus dramatically intensifies the type I PDT against hypoxic deep tumors. Moreover, benefiting from the dyad cationic feature, ENBOS achieves superior "structure-inherent targeting" abilities with the signal-to-background ratio as high as 25.2 at 48 h post intravenous injection, offering opportunities for accurate imaging-guided tumor treatment. Meanwhile, the intratumoral accumulation and retention performance are also markedly improved (>120 h). On the basis of these unique merits, ENBOS selectively inhibits the deep-seated hypoxic tumor proliferation at a low light-dose irradiation. Therefore, this delicate design may open new horizons and cause a paradigm change for PDT in future cancer therapy.